Edwards Lifesciences Corp (NYSE:EW)

CAPS Rating: 3 out of 5

A global provider of products and technologies designed to treat advanced cardiovascular disease. The Company focuses on specific cardiovascular opportunities including heart valve disease, peripheral vascular disease and critical care technologies.

Recs

0
Player Avatar NHWeston (< 20) Submitted: 9/7/2012 10:40:51 AM : Outperform Start Price: $107.23 EW Score: -53.26

As the "bionic-being" lifestyle becomes more achieveable, EW will lead the way in "auto-heart" technology.

Featured Broker Partners


Advertisement